​

OptiNose (OPTN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

OPTN Stock Forecast

OptiNose (OPTN) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $9.00 and a low of $1.00. This represents a -46.35% decline from the last price of $9.32.

- $2 $4 $6 $8 $10 High: $9 Avg: $5 Low: $1 Last Closed Price: $9.32

OPTN Stock Rating

OptiNose stock's rating consensus is Hold, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (40.00%), 3 Hold (60.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 5 0 3 2 Strong Sell Sell Hold Buy Strong Buy

OPTN Price Target Upside V Benchmarks

TypeNameUpside
StockOptiNose-46.35%
SectorHealthcare Stocks 30.37%
IndustrySpecialty & Generic Drug Manufacturers Stocks39.28%

Price Target Trends

1M3M12M
# Anlaysts-13
Avg Price Target-$9.00$4.33
Last Closing Price$9.32$9.32$9.32
Upside/Downside--3.43%-53.54%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25-13--4
Mar, 2522---4
Feb, 2522---4
Jan, 2522---4
Dec, 2422---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 21, 2025H.C. Wainwright$9.00$9.15-1.64%-3.43%
Nov 13, 2024David AmsellemPiper Sandler$1.00$0.8912.36%-89.27%
May 15, 2024Thomas FlatenLoop Capital Markets$3.00$1.12167.86%-67.81%
Nov 14, 2022BMO Capital$5.00$2.01148.76%-46.35%
Jun 13, 2022David AmsellemPiper Sandler$4.00$2.6252.67%-57.08%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 21, 2025H.C. WainwrightBuyNeutraldowngrade
Jan 03, 2025H.C. WainwrightBuyBuyhold
Nov 13, 2024Piper SandlerOverweightOverweighthold
May 15, 2024Lake StreetBuyBuyhold
Aug 21, 2023Cowen & Co.Outperforminitialise
Nov 14, 2022BMO CapitalOutperformOutperformhold
Jun 13, 2022Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.04$-1.44$-0.89$-0.32-----
Avg Forecast$-2.07$-1.46$-0.86$-4.32$-2.85$-2.21$-1.21$0.12$-0.02
High Forecast$-1.98$-1.40$-0.71$-3.93$-2.25$-0.82$0.98$2.10$-0.02
Low Forecast$-2.21$-1.56$-0.99$-4.71$-3.45$-3.57$-3.63$-1.86$-0.02
Surprise %-1.45%-1.37%3.49%-92.59%-----

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$49.12M$74.65M$76.28M$70.99M$78.23M----
Avg Forecast$50.80M$73.90M$76.00M$70.34M$76.82M$103.86M$120.59M$143.96M$199.11M
High Forecast$53.43M$77.73M$85.31M$70.63M$76.88M$122.83M$125.82M$167.91M$232.25M
Low Forecast$49.05M$71.35M$65.85M$70.04M$76.76M$89.88M$115.37M$122.88M$169.96M
Surprise %-3.31%1.02%0.36%0.92%1.82%----

Net Income Forecast

$-550M $-390M $-230M $-70M $90M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-98.33M$-81.65M$-76.39M$-35.48M$-21.54M----
Avg Forecast$-231.82M$-164.09M$-96.08M$-484.12M$-319.55M$-245.94M$-10.22M$3.15M$-2.24M
High Forecast$-221.43M$-156.73M$-79.40M$-440.58M$-252.67M$-92.23M$110.29M$235.37M$-1.81M
Low Forecast$-247.45M$-175.15M$-111.39M$-527.67M$-386.43M$-399.65M$-406.85M$-208.47M$-2.73M
Surprise %-57.58%-50.24%-20.49%-92.67%-93.26%----

OPTN Forecast FAQ

Is OptiNose stock a buy?

OptiNose stock has a consensus rating of Hold, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that OptiNose is a neutral investment for most analysts.

What is OptiNose's price target?

OptiNose's price target, set by 5 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $1 at the low end to $9 at the high end, suggesting a potential -46.35% change from the previous closing price of $9.32.

How does OptiNose stock forecast compare to its benchmarks?

OptiNose's stock forecast shows a -46.35% downside, underperforming the average forecast for the healthcare stocks sector (30.37%) and underperforming the specialty & generic drug manufacturers stocks industry (39.28%).

What is the breakdown of analyst ratings for OptiNose over the past three months?

  • April 2025: 0% Strong Buy, 25.00% Buy, 75.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is OptiNose’s EPS forecast?

OptiNose's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.21, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $-1.21 in 2026, $0.12 in 2027, and $-0.02 in 2028.

What is OptiNose’s revenue forecast?

OptiNose's average annual revenue forecast for its fiscal year ending in December 2025 is $103.86M, reflecting a 32.77% increase from the reported $78.23M in 2024. The forecast for 2026 is $120.59M, followed by $143.96M for 2027, and $199.11M for 2028.

What is OptiNose’s net income forecast?

OptiNose's net income forecast for the fiscal year ending in December 2025 stands at $-246M, representing an 1041.73% increase from the reported $-21.541M in 2024. Projections indicate $-10.219M in 2026, $3.15M in 2027, and $-2.242M in 2028.